{
  "meta": {
    "title": "Breast",
    "url": "https://brainandscalpel.vercel.app/breast-36a87332.html",
    "scrapedAt": "2025-11-30T08:50:14.387Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">HER-2/neu expression</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">ER expression</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence or absence of axillary lymph node metastasis</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Lobular carcinoma type histology (worst prognostic factor)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the single most important prognostic factor regarding invasive breast carcinoma?</span></p>",
      "unique_key": "DT1313408",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313408,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The <u>major</u> prognostic factors of invasive breast carcinoma:</p>\n<ol style=\"list-style-type: lower-roman;\">\n<li><strong><u>LYMPH NODE METASTASES:</u> Axillary lymph node status is the most important prognostic factor for invasive carcinoma in the absence of distant metastases.</strong>\n<ul>\n<li>With no nodal involvement, the 10-year disease-free survival rate is 70% to 80%</li>\n<li>3 positive nodes: the rate falls to 35% to 40%</li>\n<li>More than 10 nodes are positive: 10% to 15%</li>\n<li>It is important to note that the presence of nodal metastases is correlated with the <em><u>probability of distant metastasis,</u></em> and that <strong>removal of involved lymph nodes does not lower the risk of future metastatic disease.</strong></li>\n<li>Lymphatic vessels in most breast carcinomas drain first to <strong>one or two sentinel nodes,</strong> which can be identified with radiotracer or colored dyes.</li>\n<li>Approximately 10% to 20% of women without axillary lymph node metastases experience recurrence with distant metastasis. In these patients, metastasis may occur via the internal mammary lymph nodes or hematogenously.</li>\n</ul>\n</li>\n<li><strong><u>DISTANT METASTASES</u></strong></li>\n<li><strong><u>TUMOR SIZE</u></strong></li>\n<li><strong><u>LOCALLY ADVANCED DISEASE</u></strong></li>\n<li><strong><u>LYMPHOVASCULAR INVASION</u></strong></li>\n<li><strong><u>INFLAMMATORY CARCINOMA</u></strong></li>\n</ol>\n<p><strong>KEY TAKEAWAYS: Molecular and Biomarker Factors:</strong></p>\n<ul>\n<li><strong>ER/PR Status:</strong> Hormone receptor-positive tumors have a better prognosis.</li>\n<li><strong>HER2 Status:</strong> HER2-positive tumors have a worse prognosis but respond to targeted therapy (e.g., trastuzumab).</li>\n<li><strong>Ki-67 Proliferation Index:</strong> Higher values indicate aggressive tumor behavior.</li>\n<li><strong>BRCA Mutation Status:</strong> BRCA1/2 mutations can influence prognosis and treatment decisions.</li>\n</ul>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactational change</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Apocrine change</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">DCIS, solid variant</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">DCIS with comedonecrosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis from the following microscopic feature of the breast excisional biopsy?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123c76dc63e-89d3-4225-914d-375b4ee70acf.jpg\"></span></p>",
      "unique_key": "DT1313568",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313568,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>DUCTAL CARCINOMA IN SITU (DCIS)</strong></p>\n<p>Types of DCIS:</p>\n<ul>\n<li>Solid DCIS</li>\n<li>Cribriform DCIS</li>\n<li>Micropapillary DCIS</li>\n<li>Papillary DCIS</li>\n<li>Clinging DCIS</li>\n<li>Comedo DCIS</li>\n</ul>\n<p><strong>Comedo DCIS</strong> really refers to a <strong>pattern of necrosis,</strong> rather than an architectural pattern of DCIS, in which the involved space is lined by several layers of neoplastic epithelial cells with approximately half the space involved by necrosis.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123ef18ef89-ecda-4a08-9d1a-c213435f2cc9.jpg\">\n<p><strong>KEY TAKEAWAYS: Histological Features of DCIS:</strong></p>\n<ul>\n<li><strong>Ductal Architecture:</strong> Dilated ducts filled with neoplastic cells.</li>\n<li><strong>Central Necrosis:</strong> Characteristic <strong>\"comedo\" necrosis with eosinophilic debris</strong> in the ductal center.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123c2632a61-1192-4294-a9e4-2cb7bf592d15.jpg\">\n<ul>\n<li><strong>High Nuclear Grade:</strong> Pleomorphic, hyperchromatic nuclei with mitotic activity.</li>\n<li><strong>Calcifications:</strong> Dystrophic calcifications often seen in necrotic areas</li>\n</ul>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">It is associated with Klinefelter syndrome</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">This is not a precancerous lesion</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">It can be associated with leydig cell tumor</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased androgenic activity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man has a 3-cm breast mass (see image). What is FALSE for this lesion?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501238b43c442-eec2-49b7-90ba-f5f3c85f66bf.jpg\"></span></p>",
      "unique_key": "DT1313570",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313570,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Gynecomastia (enlargement of the male breast):</strong></p>\n<ul>\n<li>The only benign (choice B) lesion seen with any frequency in the male breast</li>\n<li>Presents as a <strong>button-like subareolar enlargement</strong></li>\n<li>Unilateral or bilateral</li>\n<li><u>Microscopically</u> - there is an increase in dense collagenous connective tissue associated with epithelial hyperplasia of the duct lining. Lobule formation is almost never observed (see image)</li>\n<li>Relative increase in estrogenic activity (whether endogenous or exogenous), <strong>decrease in androgenic activity</strong> (Choice D), or both.</li>\n<li>Puberty or in the very aged <strong>(relative increase in estrogens as testicular androgen production falls)</strong></li>\n<li>Gynecomastia is associated with -\n<ul>\n<li><strong><u>CIRRHOSIS OF THE LIVER</u></strong>, since this organ is responsible for metabolizing estrogen.</li>\n<li>Drugs such as <strong>alcohol, marijuana, heroin, antiretroviral therapy, and anabolic steroids</strong></li>\n</ul>\n</li>\n<li>Gynecomastia occurs as part of <strong>Klinefelter syndrome (XXY karyotype) (Choice A)</strong> or in <strong>association with functioning testicular neoplasms, such as Leydig cell or Sertoli cell tumors. (Choice C)</strong></li>\n</ul>\n<p><strong>KEY TAKEAWAYS:</strong></p>\n<p><strong>Causes of Gynecomastia</strong></p>\n<ol>\n<li><strong>Physiological:</strong>\n<ul>\n<li><strong>Neonatal:</strong> Maternal estrogen.</li>\n<li><strong>Pubertal:</strong> Hormonal imbalance during adolescence.</li>\n<li><strong>Elderly:</strong> Decreased testosterone levels with age.</li>\n</ul>\n</li>\n<li><strong>Hormonal Imbalance:</strong>\n<ul>\n<li><strong>Increased Estrogen:</strong> Testicular tumors, adrenal tumors, obesity.</li>\n<li><strong>Decreased Androgens:</strong> Hypogonadism (Klinefelter syndrome, testicular injury).</li>\n</ul>\n</li>\n<li><strong>Endocrine Disorders:</strong>\n<ul>\n<li>Hyperthyroidism.</li>\n<li>Chronic liver disease (increased aromatization of androgens).</li>\n</ul>\n</li>\n<li><strong>Drugs:</strong>\n<ul>\n<li><strong>Hormonal:</strong> Estrogens, anti-androgens (flutamide, spironolactone).</li>\n<li><strong>Non-hormonal:</strong> Ketoconazole, cimetidine, digoxin, antipsychotics, chemotherapy.</li>\n</ul>\n</li>\n</ol>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Intraductal papilloma</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Sclerosing papilloma</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoma arising in a papilloma</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Solid Papillary carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old woman is found to have a 2 cm subareolar, breast mass accompanied by serosanguinous discharge. Based on the following image, what is the best diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501230753e9eb-4ba5-4892-9dbd-353e2f223e97.jpg\"></span></p>",
      "unique_key": "DT1313572",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313572,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>Papillomas grow <strong>within a dilated duct</strong> and are composed of multiple branching <strong>FIBROVASCULAR CORES.</strong></li>\n<li><strong>Benign intraductal proliferation</strong> composed of papillary projections with fibrovascular cores, covered by <u>epithelial <strong>and</strong> myoepithelial layers.</u></li>\n<li>Epithelial hyperplasia + apocrine metaplasia</li>\n<li><strong><u>LARGE DUCT PAPILLOMAS</u></strong>: Nipple discharge+, may be bloody due to torsion of the stalk, leading to infarction. Serous discharge results from intermittent blockage and release of normal breast secretions or irritation of the duct by the papilloma.</li>\n<li>In the lactiferous sinuses of the nipple</li>\n<li>Solitary</li>\n<li><strong><u>SMALL DUCT PAPILLOMAS</u></strong>: Small palpable masses, or as densities or calcifications seen on mammograms.\n<ul>\n<li>Located deeper within the ductal system</li>\n<li>Multiple</li>\n</ul>\n</li>\n<li>Serous discharge results from intermittent blockage and release of normal breast secretions or irritation of the duct by the papilloma.</li>\n</ul>\n<p><strong>KEY TAKEAWAYS:</strong> Intraductal papilloma-A benign tumor of the breast arising from the epithelial lining of lactiferous ducts.</p>\n<p><strong>Pathology:</strong></p>\n<ul>\n<li>Fibrovascular core covered by benign ductal epithelium.</li>\n<li>May have focal atypia or associated ductal carcinoma in situ (DCIS).</li>\n</ul>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosome 13q12</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosome 17q21</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosome 3p</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromosome 11q32</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The BRCA1 gene is located on:</span></p>",
      "unique_key": "DT1313574",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313574,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Mutations in BRCA1 and BRCA2</strong> are responsible for 80% to 90% of <strong>single gene familial breast cancers</strong> and about 3% to 6% of all breast cancers.</p>\n<ul>\n<li>Mutations in <strong>BRCA1</strong> also markedly <em><u>increase the risk of ovarian carcinoma,</u></em> which occurs in 20% to 40% of carriers.</li>\n<li><strong>BRCA2</strong> confers a smaller risk for ovarian carcinoma (10% to 20%) but is associated more frequently with <em><u>male breast cancer</u></em>.</li>\n<li><strong>BRCA1 and BRCA2</strong> carriers also are at higher risk for other epithelial cancers, such as <em><u>prostatic and pancreatic carcinoma</u></em>.</li>\n</ul>\n<p><strong>KEY TAKEAWAYS:</strong></p>\n<ul>\n<li><strong><u>BRCA1 (on chromosome 17q21)</u></strong></li>\n<li><strong><u>BRCA2 (on chromosome 13q12.3)</u></strong></li>\n</ul>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with BRCA 2 mutations</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Late rate of recurrence</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary breast carcinoma features</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal-like gene expression profile</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is TRUE about Triple negative breast cancer (TNBC)?</span></p>",
      "unique_key": "DT1313578",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313578,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>TNBCs</strong> arise through an <strong>estrogen-independent pathway</strong> that is</p>\n<ul>\n<li>Not associated with HER2 gene amplification</li>\n<li>15% of breast cancers</li>\n<li>\"Basal-like\" gene expression profile (normally expressed in basally located myoepithelial cells) (choice D)</li>\n<li>A <em><u>possible precursor lesion</u></em>: Lobular epithelial cells that are <strong>ER-negative</strong> and <strong>p53-positive,</strong> the latter being a feature that correlates with the presence of <em><u>TP53 mutations</u></em>.</li>\n<li>TNBC is associated with germline <strong>BRCA1 mutations. (Choice A)</strong></li>\n<li>The only gene that is mutated in the majority of these cancers is <strong>TP53</strong></li>\n<li>Present as a <u>palpable mass</u></li>\n<li>Treatment: <strong>Cytotoxic therapy</strong> combined with agents that are selectively active against cancers with defective homologous recombination results in complete or almost complete responses in about a third of cases.</li>\n<li>Papilloma Carcinoma features - seen in <strong>Luminal A (choice C)</strong></li>\n<li>Medullary carcinoma features - seen in <strong>Triple negative breast cancer</strong></li>\n<li>The cancers that recur usually do so in the <em><u>first 8 years after diagnosis.</u></em></li>\n</ul>\n<p><strong>KEY TAKEAWAYS:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501230387e488-5b19-45c3-9883-6cab2a076924.jpg\">",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytokeratin 7</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">p63</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">E-cadherin</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Cytokeratin 20</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following immunohistochemical stains can most reliably differentiate invasive ductal carcinoma from lobular carcinoma?</span></p>",
      "unique_key": "DT1313581",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501233a2a706f-a994-461b-993c-87ce0a8a029c.jpg\">",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Lobular carcinoma of the breast</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with ionizing radiation</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Pagetoid spread</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is TRUE about CDH1 associated breast cancer?</span></p>",
      "unique_key": "DT1313585",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313585,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>CDH-1 associated breast cancer</strong></p>\n<p>Inactivating germline mutations in <strong>CDH1 (gene for E-cadherin)</strong> resulting in characteristic <strong>lobular carcinoma</strong> of the breast</p>\n<p>Most CDH1 mutations are associated with <strong>Hereditary diffuse gastric cancer (HDGC),</strong> which also has germline mutations in CDH1 and can have lobular carcinoma of the breast also.</p>\n<p>E-cadherin is important for <u>cell adhesion</u> and <u>tumor suppression</u></p>\n<p><strong>KEY TAKEAWAYS:</strong> Classic HDGC finding: Signet ring carcinoma in situ</p>\n<ul>\n<li>Signet ring cells above basement membrane</li>\n<li>Pagetoid spread</li>\n<li>Can then progress to invasive, diffuse gastric cancer</li>\n<li>Often multifocal</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501234d1b6114-8bc7-4e0a-9582-970328127911.jpg\">\n<p>Reference: https://www.webpathology.com/images/gastrointestinal/stomach/gastric-carcinomas/42016</p>",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">The most common location is lower inner quadrant</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Breast carcinoma is slightly more frequent in the left breast than in the right</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Multicentricity more common in lobular than in ductal carcinomas</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Multifocality was more commonly seen with invasive ductal carcinomas</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the incorrect statement about breast carcinoma from the following.</span></p>",
      "unique_key": "DT1313588",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313588,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Multicentricity</strong> <u>more common in lobular than in ductal carcinomas (choice c)</u></li>\n<li>Younger patients have <u>larger tumors</u>, to have <u>lymphovascular space invasion</u> and <u>positive lymph nodes</u>.</li>\n<li><strong>Multifocality</strong> was more commonly seen with invasive ductal carcinomas (choice D)</li>\n<li>Breast carcinoma is slightly more frequent in the left breast than in the right (choice B)</li>\n<li>The location of breast carcinoma is usually indicated in relation to the breast quadrants.\n<ul>\n<li>Approximately 33% are in the upper outer quadrant (choice A)</li>\n<li>9% in the upper inner quadrant</li>\n<li>6% in the lower outer quadrant</li>\n<li>5% in the lower inner quadrant</li>\n<li>7% in the central region (within 1 cm of the areola)</li>\n<li>40% occur in overlapping quadrants</li>\n</ul>\n</li>\n</ul>\n<p><strong>KEY TAKEAWAYS:</strong> Breast cancer is more common in upper outer quadrant.</p>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Myofibroblastoma</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Intraductal papilloma</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Ductal carcinoma in situ</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Phyllodes tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">This is a breast core biopsy of a 4.5 cm lesion in a 50-year-old woman. It is round rubbery and well-circumscribed on palpation. Based on the following image, what is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501233d32c17e-1220-4516-b047-4dc4b8154233.jpg\"></span></p>",
      "unique_key": "DT1313597",
      "question_audio": null,
      "question_video": null,
      "map_id": 1313597,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>PHYLLODES TUMOR</u></strong></p>\n<ul>\n<li>Fibroepithelial neoplasm with prominent Intracanalicular growth and stromal hypercellularity</li>\n<li>Exaggerated intracanalicular growth &rarr; <strong>\"Leaf-like\"</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250123416970b2-0108-4150-8c27-fd2e878bbd85.jpg\">\n<ul>\n<li>Projections into variably dilated lumina</li>\n<li><strong>Increased stromal cellularity, particularly accentuated, Adjacent to the epithelium. Sometimes heterogeneous</strong>.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501233ef0b089-e6a8-4b32-ac07-de985e3347ec.jpg\">\n<p><strong>Malignant phyllodes</strong> show:</p>\n<ul>\n<li>Stromal overgrowth (4x field without epithelium)</li>\n<li>Increased mitoses (&ge;10 per 10 HPFs)</li>\n<li>Increased stromal cellularity (Often diffuse)</li>\n<li>Infiltrative borders</li>\n<li>Malignant heterologous elements (except well-differentiated liposarcoma, As it has a low metastatic risk)</li>\n</ul>\n<p>When a Tumor has some but not all the features of malignancy, consider \"Borderline\".</p>\n<ul>\n<li>Molecular: Recurrent <strong>MED12 mutations</strong> support a shared pathogenesis with Fibroadenomas.</li>\n<li>Additional mutations include: TERT, TP53, PTEN, RB1, and EGFR</li>\n<li><strong><u>INTRADUCTAL PAPILLOMA:</u></strong> (Choice B)\n<ul>\n<li><strong>Benign intraductal proliferation</strong> composed of papillary projections with fibrovascular cores, covered by <u>epithelial <strong>and</strong> myoepithelial layers.</u></li>\n</ul>\n</li>\n<li><strong><u>MYOFIBROBLASTOMA:</u></strong> (choice A)\n<ul>\n<li>Benign tumor of mammary stroma composed of fibroblasts and myofibroblasts.</li>\n<li>Purely mesenchymal lesion.</li>\n<li>No epithelium or myoepithelial cells.</li>\n</ul>\n</li>\n</ul>\n<p><strong>KEY TAKEAWAYS:</strong> Phyllodes tumor is a rare fibroepithelial neoplasm of the breast, characterized by stromal and epithelial components, with potential for malignant behavior.</p>\n<p><strong>Pathology</strong></p>\n<ol>\n<li><strong>Gross Features:</strong>\n<ul>\n<li>Large, well-circumscribed mass with a <strong>leaf-like (phyllodes) architecture</strong>.</li>\n<li>Cut surface shows a cystic and solid appearance.</li>\n</ul>\n</li>\n<li><strong>Microscopic Features:</strong>\n<ul>\n<li><strong>Biphasic tumor with hypercellular stroma and epithelial-lined cleft-like spaces.</strong></li>\n<li>Stromal overgrowth with varying degrees of atypia and mitotic activity.</li>\n</ul>\n</li>\n</ol>",
      "correct_choice_id": 94,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}